Premium
Postchemotherapy retroperitoneal residual mass in infantile yolk sac tumor
Author(s) -
KUO JUNNEYIH,
HSIEH YUHLIN,
CHIN TAIWEI,
WEI CHOUFU,
CHEN KUANGKUO,
CHANG LUKE, S
Publication year - 1999
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.1999.06218.x
Subject(s) - yolk sac , medicine , cisplatin , chemotherapy , metastasis , retroperitoneal lymph node dissection , radiology , pathology , surgery , cancer , testicular cancer , embryo , biology , microbiology and biotechnology
Background: Persistent postchemotherapy retroperitoneal residual mass with normalization of α‐fetoprotein (AFP) in infantile yolk sac tumor is rare. Methods/Results: A 38‐month‐old boy with recurrent yolk sac tumor was treated with cisplatin‐based combination chemotherapy. After chemotherapy, the retroperitoneal lymph node metastasis, 7 x 6 cm in size, decreased to 2 x 2 cm. Serum AFP levels returned to normal. The retroperitoneal residual mass was resected and histologically showed complete necrosis without viable cancer cells. Conclusion: The patient has remained free of disease for 36 months after operation.